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Summary 
During the study of autoimmune models we found that (SWR  x  SJL)F1 mice (both parental 
strains with the V3 a phenotype) spontaneously produced immunoglobulin G (IgG) antibodies 
directed against SIn/U1 small nuclear ribonucleoproteins (snRNPs).  In some of these females, 
the presence of these autoantibodies was found as early as 10 wk of age. Their frequency increased 
with age i.e.,  70%  at 40 wk. At that time, only 10% of males developed anti-Sm/UlsnRNP 
antibodies. Anti-Sm/UlsnRNP antibodies from positive mice generally recognized the peptides 
BB', D, 70 kD,  and A  from RNPs.  These polypeptides are known to bear the autoantigenic 
epitopes that are recognized by human sera containing anti-Sm and anti-UlsnRNP antibodies. 
Reactivity of IgG antibodies with the octapeptide sequence PPPGMRPP was also found in 30% 
of anti-Sm/UlsnRNP  positive  (SWR  x  SJL)F1 mice that  precipitated  BB'  peptides.  This 
octapeptide has been described as the most immunoreactive linear epitope in systemic lupus 
erythematosus (SLE) patients with anti-Sm and anti-UlsnRNP antibodies. Approximately 30% 
of anti-Sn/UlsnRNP  positive females,  later produced anti-dsDNA antibodies.  This fact was 
accompanied  by  the  development  of  proteinuria  due  to  glomerulonephritis  mediated  by 
immunocomplexes. In addition to the specific autoimmune response, (SWR  x  SJL)F1 females 
also  showed  other  immunologic  abnormalities  such  as  hypergammaglobulinemia,  and  an 
approximately twofold increase in spleen cell number compared with control mice. These results 
indicate that (SWR  x  SJL)F1 females develop clinical and serological abnormalities similar to 
those observed in human SLE and constitute a novel model for the study of the genetic mechanisms 
that result in autoimmunity. 
T 
he etiopathogenesis of autoimmune diseases cannot readily 
be analyzed without appropriate animal models. With 
regard to experimental autoimmune connective tissue diseases, 
we can divide these models into two wide groups: (a) inbred 
mice that spontaneously develop a disease similar to human 
SLE (1); and (b) chronic GVHD induced in hybrid F1 mice 
injected with lymphoid parental cells (2).  In the latter, au- 
toantibodies against different antigenic specificities and aspects 
of different autoimmune connective diseases are developed 
when different strains of mice are employed (3,  4). 
In the studies on GVHD performed in our laboratory (3, 
4),  we have employed F1 hybrids generated by crosses be- 
tween different strains of mice. SWR and SJL were selected 
because both are deficient in nearly 50% of Vfl genes (Vfl  a 
haplotype). In addition they lack I-E expression and carry 
a functional gene for Vf117 (Vfl17a)  (5). We wanted to ex- 
plore the effect of their reduced Vfl repertoire on the clinical 
and biological expression of GVHD induced by the injection 
of lymphoid cells from either parental strain. 
In the course of control experiments aimed at characterizing 
the control hybrid mice, we found that  many (SWR  x 
SJL)F1 mice spontaneously developed antinuclear antibodies 
in their serum. 
This study was undertaken to characterize the clinical and 
serologic aspects of the autoimmune disease that (SWR  x 
SJL)F1 mice spontaneously develop. 
Materials and Methods 
Mice 
SWR  (H-2q),  SJL/J  (H-2s),  (SWR  x  SJL)F1 (SJL  x 
SWR)F1, BALB/c (H-2d), A/J (H-2a), MILL lpr/lpr (H-2k), and 
C57BL/6 (H-2b) mice were purchased from The Jackson Labora- 
tory (Bar Harbor, ME), and housed in the animal facilities of the 
Hospital de Sant Pau. 30 females and 25 males were 8-wk-old at 
the beginning of the study. Animals were bled from the retroor- 
bital sinus and the sera were stored frozen at  -20~ 
Clinical Studies 
At weekly intervals, mice were inspected for any external signs 
of pathology (alopecia, skin sclerosis, ascitis, and joint swelling). 
Combur's test was used to study urine samples for elevated levels 
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cessed for immunohistologic studies. 
Serologic Studies 
Indirect Immunofluorescence.  Sera were screened for antinuclear 
antibodies (ANA) using the indirect immunofluorescence technique. 
Hep-2 cells grown on glass slides were fixed and used as substrate. 
The fluorescein-labeled anti-mouse conjugate was purchased from 
Sera-Lab Limited (Crawl Down, Sussex, UK) and used at a dilu- 
tion of 1:20. 
Analysis oflmmunoprecipitatedRNAs.  To identify ANAs capable 
of binding specific small nuclear ribonucleoproteins (snRNPs) 1, 
sera were tested for their ability to immunoprecipitate subsets of 
small RNAs from extracts of murine Friend erythroleukemia cells, 
as described  previously (3). 
Analysis oflmmunoprecipitated Proteins.  A procedure based on 
that of Matter et al. (6) was used. Briefly, HeLa cells growing in 
log phase at 2  x  10  s cells/ml were allowed to incorporate [3SS]me- 
thionine (5 #Ci/ml) for 16-18 h. For protein immunoprecipita- 
tion, we used protein A-Sepharose particles previously reacted with 
an IgG class rabbit anti-mouse IgG. The immunoprecipitated pro- 
teins  were  separated  and  analyzed  by electrophoresis on  12% 
polyacrylamide-SDS  gels, as described by Laemmli (7). After elec- 
trophoresis, the gel was soaked in 0.5 M  sodium salicylate. The 
gels were dried and exposed to x-ray film with an intensifying screen 
at  - 70  ~ 
Immunoblots.  Immunoblot analysis was performed as described 
(4). Briefly, HeLa cell extracts, or U1-U6 snKNP-enriched extracts 
consisting of the eluates from a human anti-UlsnRNP and anti- 
Sm immunoaflqnity columns charged with whole extracts of HeLa 
cells, were subjected to gel electrophoresis and the proteins were 
transferred to nitrocellulose.  The membrane was blocked with 3% 
(wt/vol) dry skim dry milk in PBS for 4 h and then incubated 
overnight with  serum  (1:100 dilution) in the same buffer.  The 
nitrocellulose strips were washed with PBS and PBS/0.1% Tween 
20  and  then  incubated  for  30  min  with  125I-labeled rabbit 
anti-mouse IgG (0.1 #Ci/ml; Du Pont de Nemours, Brussels, Bel- 
gium). After four washes with PBS, the strips were air-dried  and 
subjected  to autoradiography. 
Autoantibodies Reacting with the Octapeptide Sequence (PPPGMR- 
PP).  A peptide corresponding to the sequence PPPGMRPP was 
synthesized in solid-phase using an automatic synthesizer (model 
430A; Applied Biosystems Inc., Foster City, CA). It was conjugated 
to BSA by the MBS method of Cys COOH-terminal (10.33 tool 
peptide/mol BSA). To detect serum autoantibodies against this oc- 
tapeptide,  the conjugate was  coated onto polystyrene plates  (5 
#g/well) and ELISA was performed as previously described (3). 
Anti-Sin and anti-UlsnRNP control sera were obtained from five 
SLE patients.  Other control sera included in this study were: 8 
MRL/lpr sera (three of them presented anti-Sm antibodies) and 
10  sera  from  mice of each  of the  following  strains:  BALB/c, 
C57BL/6, SJL,  and SWR. 
Antibodies to Native DNA.  Antibodies to double-stranded DNA 
were measured by ELISA as described elsewhere (3). Briefly, pBR322 
DNA (Boehringer Mannheim, Indianapolis,  IN) was added at 5 
#g/ml to microtiter plates previously coated with poly-t-lysine (50 
#g/ml; Sigma Chemical Co., St. Louis, MO). After a 1-h incuba- 
tion with blocking buffer (10% FCS in 0.01 M Tris-HC1, 0.05% 
Tween-20, pH 7.4), sera were added (1:100 diluted) and bound an- 
tibodies detected with peroxidase-conjugated  goat anti-mouse IgG. 
If the results exceeded the mean  +  2o of 20 normal control sera, 
they were considered  positive. 
Determination of lgG, IgM, and lgA Concentrations in Sera.  IgG, 
IgM, and IgA levels were measured from sera by a commercial radial 
immunodiffusion assay (The Binding Site, Birmingham,  UK). 
Lymphoid  Cell Phenotype 
Lymph nodes and spleens were aseptically removed from 40-wk- 
old mice, and the tissues minced in sterile PBS and pressed through 
a fine screen to form single cell suspensions.  Spleen cell suspen- 
sions were treated briefy with an ammonium chloride buffer to 
lyse erythrocytes. 
Absolute lymphocyte count and lymphocyte subsets were studied 
by flow cytometry analysis, mAbs against  Thyl (Sera Lab), Lyl 
(Becton Dickinson, San Diego, CA), CD4 (Becton Dickinson), 
CD8 (Sera Lab), B220 (American Type Culture Collection, Rock- 
ville, MD) were either FITC labeled or used as biotin-conjugated 
reagents and developed by means  of streptavidin-PE.  Cells were 
stained following standard protocols and fluorescence was measured 
using a flow cytometer (Epics Profile; Coulter Cytometry, Hia- 
leah, FL). Background values were defined by using isotype-matched 
irrelevant  antibodies  as negative controls. 
Results 
Clinical Course  of (SI,  VR  x  SJL)F,  Mice 
All mice remained healthy until they were 20-wk-old. At 
20 wk of age,  10%  of females but  none of the males had 
developed proteinuria (1 mg/ml). At 40 wk, 26% of females 
and  none of the males  had developed proteinuria. 
10 females, 4 of them with proteinuria, were killed when 
they were 40-wk-old, and their kidneys were examined histo- 
logically. The immunofluorescence studies showed that the 
four animals with proteinuria presented granular deposits of 
IgG and C3 of variable intensity (Fig.  1) and another three 
mice showed mesangial deposits of IgG. No signs of alopecia, 
vasculitis, or arthritis were observed in mice during the 40-wk 
study. 
A marked splenic and lymph node hyperplasia was observed 
in (SWR  x  SJL)F1 mice as well as in both parental strains. 
The degree of splenic and lymph node hyperplasia resulted 
in sizes ranging from two to three times the size of spleen 
Table  1.  Number of Mononuclear Spleen Cells 
No.  mononuclear spleen  cells 
Strain  ( x  106 cells) 
SWR  133  +  5 
SJL  128  +  6 
(SWR  x  SJL)F1  145  -+  10 
BALB/c  87  +  3 
A/J  79  _+ 2 
x Abbreviation used in this paper: RNP, ribonucleoprotein. 
Results are expressed as the mean -+ SD of the number of mononuclear 
cells from the spleens of 10 mice. 
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),sis of kidney sections using fluoresceinated 
sheep anti-mouse IgG. Granular  deposits  along 
the glomerular capillary  walls and mesangium 
are present. 
Table  2.  Phenotype of Spleen Lymphocytes 
Marker  BALB/c  SJL  SWR  WXJF1 
B220  44.3  -+  4  41.4  _+  2  54  -+  4  50.1  _+  2 
Thyl  38.3  -+  3  37.2  _+  0.9  33.7  -+  4  29.5  _+  1 
CD8  15.1  -+  0.7  13.4  _+  0.4  8.5  -+  2  7.4  _+  2 
CD4  30.1  -+  1.2  32.3  _+  2  26.6  +  0.4  26.1  _+  3 
Lyl  43  +  5  41.3  _+  1  32.2  -+  4  40  +  3 
Values represent the mean  _+  SD of the relative frequency of positively stained cells from 10 BALB/c, 5 SJL, 5 SWR, and 10 (SWR X SJL)F1 mice. 
Table  3.  Serum Ig Levels in Several Strains of Mice 
IgG  IgM  IgA 
Age  <20  wk  >30  wk  <20  wk  >30 wk  <20  wk  >30  wk 
/~g/ml 
BALB/c  2,190  4,068  390  410  400  1,100 
B6  1,590  2,920  210  240  ND  ND 
MRL  +  9  1,500  6,900  310  405  ND  ND 
MRL  lpr  19,000  30,150  600  1,600  1,525  4,950 
SWK 9  ND  9,400  ND  254  ND  5,332 
SJL  9  ND  11,000  ND  250  ND  1,020 
WXJF1  9  5,177  10,100  344  425  1,000  4,772 
WXJF1  ce  1,819  7,100  190  400  350  1,110 
The concentration of the mouse Ig (IgG, IgM,  and IgA) was determined by radial immunodiffusion assay (The Binding Site). 
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labeled Friend leukemia  cell extracts. (A) Lanes 1-21 show 
the precipitates with sera from 20-wk-old (SWR ￿  SJL)F1 
females. (B) Lanes 1-5 show the precipitates with sera from 
40-wk-old SWR females  and lanes 6-10 to SJL females. (C) 
Corresponds to a representative  experiment  including  the two 
positive sera (lanes 6 and 7) from 40-wk-old  (SWR ￿  SJL)F1 
males. The total RNA lane contains 1/~ml of whole cell ex- 
tract. Sera  from a human patient known to have  anti-Sin an- 
tibodies and sera from a normal mouse  are included  as con- 
trols. Small KNAs were identified  from their characteristic 
electrophoretic mobilities. 
and  lymph  nodes  from  control  mice (BALB/c,  A/J,  and 
C57BL/6). 
The splenic hyperplasia matched with the increased number 
of mononuclear spleen cells  (Table  1). 
Lymphocyte Markers 
Data obtained by flow cytometry  showed that the percentage 
of spleen cell was approximately half in the spleen of (SWR  ￿ 
SJL)F1 and SWR mice as compared with control mice (Table 
2). Moreover, SWP. and (SWR  x  SJL)F1 spleens presented 
an increase in the percentage of B220 + and (SWR  x  SJL)F1 
spleens a decrease in  the percentage of Thyl + 
Serologic Manifestations 
Serum Ig Levels.  IgM, IgA, and IgG levels in serum from 
young adults (<20 wk) and older SWR, SJL, and (SWR  x 
SJL)F1 mice were compared with those observed in normal 
and autoimmune strains of mice (Table 3). The three Ig iso- 
types increased significantly with the age of the (SWR  x 
SJL)F1 mice. 
Serologic analysis indicated that serum IgG levels in young 
adult and 30-wk-old (SWR  x  SJL)Fi females as well as 30- 
wk-old SWR. and SJL mice were increased two and five times 
compared with control sex- and age-matched BALB/c and 
C57BL/6 mice, respectively. No difference in serum IgM levels 
was observed. IgA levels were four- to fivefold higher in SWR 
and  (SWR  x  SJL)F1 females  as  compared with  control 
females. 
IgG Class Antibodies to Nuclear Antigens.  IgG antibodies 
against nuclear components were detected by IIF in the sera 
of 30% of 10-wk-old females. The titers ranged between 1/160 
and  1/640  and  speckled  patterns  were commonly found. 
Among 40-wk-old mice, the frequency of ANAs rose to 70% 
of (SWR  x  SJL)F1 females. During the evolution in eight 
animals the speckled patterns were changed or hidden by a 
homogeneous one. Only 20% of 40-wk-old males were ANA 
positive with titers between 1/40 and 1/80. In no cases did 
the titer decrease  or become negative. 
Anti-Sm/UlsnRNP  Antibodies.  The  presence  of  anti- 
Sm/UlsnRNP autoantibodies in sequential serum samples 
of control and (SWR  x  SJL)Ft  mice was assessed by im- 
munoprecipitation and analysis of small RNAs. 30 (SWR  x 
SJL)FI  females,  25  (SWR  x  SJL)F1 males,  as  well as 30 
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and 15 SJL) were studied. Immunoprecipitated UsnRNAs 
appeared in 10% of (SWR  x  SJL)F1 females at '~10 wk of 
age, progressing thereafter to 50% at 20 wk and 70% at 40 
wk of age. Fig. 2 shows a representative experiment in which 
sera from 21 (SWR,  x  SJL)F1 20-wk-old females were ex- 
amined (A). None of the sera from parental SWR and SJL 
strains precipitated UsnRNAs. At 10 wk of age, none of the 
(SWR  x  SJL)F1 males presented anti-Sm/UlsnRNP anti- 
bodies,  and only 10% of them showed this antibody speci- 
ficity at 40 wk. A representative  experiment that included 
sera of the two positive and seven negative (SWR  x  SJL)F1 
males, as well as five sera of SJL and five SWR mice is shown 
(Fig.  2,  B  and C).  Significantly,  as the image reveals, the 
precipitate  of the (SWR  x  SJL)F1 male positive sera are ex- 
tremely weak. 
(SWR  x  SJL)F1 sera that precipitated UsnRNAs, preci- 
pitated from HeLa cell extracts a set of polypeptides with 
molecular weights compatible with those described for the 
components of Sm particles.  The major proteins found in- 
cluded A, B'/B, C, D, E, F, and G. None of the sera from 
parental SWR and SJL strains  precipitated the polypeptide 
components of the Sm/U1RNP particles.  Male (SWR  x 
SJL)F1 mice sera that showed this antibody specificity weakly 
precipitated the components of Sm particles  (Fig. 3).  Only 
Figure  3.  Proteins  immunoprecipitated  from 3sS-labeled HeLa  cell ex- 
tracts. (A) The precipitate  with eight representative  (SWtL x SJL)F1  fe- 
male sera, four of them anti-Sm positive (mouse  no. 14, 12, 28, and 13) 
and four of them anti-Sm negative (mouse no. 8, 15, 16, and 17). (B) 
The precipitate  with sera from  three  40-wk-old  SWR female  mice  (mouse 
nos. I-3) and three  40-wk-old  SJL mice  (mouse  no. 6-8). (C) The precipi- 
tate with 40-wk-old (SWR  x  SJL)F1 male sera, including the two 
anti-Sin positive  sera (mouse  no. 6 and 7). Sera from a MRL/lpr mouse 
(lane MRL/1) and from a SLE patient (lane  anti-Sin) both with anti-Sm 
antibodies, were  used  as positive  controls.  Sera from  a normal  mouse  (nras) 
is included  as a control The precipitates  were  separated  by ehctrophoresis 
on 12% polyacrylamide-SDS  gel and visualized  by fluorography. 
the A  protein appeared  in the image because  of the small 
amount of antibody in their sera. To identify the antigenic 
polypeptides recognized by antilSm/UlsnRNP antibodies, 
sera from 16 (SWR  x  SJL)F1 females were tested in immu- 
noblots using HeLa extracts. The peptides 70 kD (15 of 16 
mice), B'/B (13 of 16), A  (3 of 16), and D  (3 of 16) were 
1433  Vidal et al. Figure  4.  Identification  of Sm/ 
UlsnRNP polypeptides  that are rec- 
ognized by sera from six (SWR x 
SJL)F1 female  sera that immunopre- 
cipitated snRNPs (mouse no. 9, 12, 
13, 14, 18, and 19). lmmunoaffinity 
purified  Sm/UlsnRNP  particles  were 
fractionated electrophoretically  and 
transferred  to nitrocellulose  paper. The 
snRNP polypeptides  are identified  by 
their electrophoretic  mobility  and rec- 
ognized by a serum known to con- 
tain anti-Sm/U1 snRNP antibodies. 
Sera from a (SWR x SJL)F1  mouse 
that  did  not  precipitate snRNA 
(mouse no. 1) and a normal mouse 
serum (nms) are included  as controls. 
the main targets of these sera. Fig. 4 shows a representative 
immunoblotting experiment. 
Other unidentified peptides were observed by the analysis 
of immunoprecipitated proteins of HeLa cell extracts as well 
as by immunoblot assay. 
30%  of female sera that recognized B/B' peptides were 
reactive with the synthetic octapeptide PPPGMRPP, the most 
immunoreactive linear epitope that has been described in SLE 
patients with anti-Sm/UlsnRNP antibodies (8). None of the 
anti-Sm/UlsnRNP negative sera were reactive with this pep- 
tide (Fig.  5). 
Anti-clsDNA  Antibodies.  Anti-dsDNA antibodies were first 
detected in 20-wk-old females (2 of 30),  progressing there- 
after to 9 positive out of 30 mice when they were 40-wk-old 
(Fig.  5). 
The presence of anti-dsDNA antibodies was associated with 
glomerulonephritis mediated by immunocomplexes. It is in- 
teresting to note that glomerular deposits of IgG involving 
the mesangium but not the glomerular capillary walls were 
observed in mice that developed exclusively anti-Sm antibodies. 
Discussion 
In this paper we demonstrate that the hybrid (SWP,  x 
SJL)F1 as  well  as  (SJL  x  SWR)F1  female mice  present 
hypergammaglobulinemia  and lymphoid hyperplasia and fre- 
quently develop proteinuria and anti-Sm and anti-UlsnRNP 
antibodies. The latter are not present in any of the autoim- 
mune strains of mice described previously.  The spontaneous 
production of specific anti-Sm antibody (9) had been found 
exclusively in SLE patients and the autoimmune MRL strains. 
The target peptides of these autoantibodies are the B'/B and 
D, that have been described previously in the MILL mice and 
in SLE patients with anti-Sm antibodies, and the A and 70- 
kD polypeptides, described previously in mixed connective 
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Figure  5.  Levels  of antioctapeptide  PPPGMRPP and anti-dsDNA an- 
tibodies in sera from (SWR x  SJL)F1  mice with anti-Sm/U1 snRNP 
antibodies (A) or without  anti-Sm/U1 snRNP antibodies  (A). OD values 
were determined  by an enzyme-linked  immunoassay.  Horizontal  lines show 
the mean plus 2 SD value in 20 normal mouse sera (10 BALB/c  and 10 
C57BL/6). 
tissue disease (MCTD) and SLE patients with anti-UlsnRNP 
antibodies. These data and the high restriction of anti-Sm 
antibodies for SLE suggested that factors similar to those that 
operate in human SLE and MRL mice are driving the re- 
sponse against these antigenic specificities. However, the re- 
sponse to the linear epitope described as the main target of 
all the human anti-B'/B Sm antibodies is only detected in 
the 30%  of anti-Sm/UlsnRNP positive (SWR  x  SJL)FI 
mice, suggesting that stochastic mechanisms such as V gene 
rearrangement or V gene somatic mutations may be involved 
in the heterogeneity of this response. 
Although the frequency of anti-Sm antibodies in (SWR ￿ 
SJL)F1 females is similar to that described in MtLL/n females 
(10), MRL/n males developed anti-Sm antibodies with a higher 
frequency than (SWR  x  SJL)F1 males.  Moreover,  40-wk- 
old (SWR  x  SJL)F1 males presented a significant low inci- 
dence,  low titer,  and a later development of anti-Sin anti- 
bodies than females. Sexual hormones in (SWR  x  SJL)F1 
females may be operating as possible enhancing factors in the 
induction of anti-Sin and anti-UlsntLNP autoantibodies. 
Anti-dsDNA is another autoantibody specificity frequently 
present in the sera of SLE patients and in other SLE strains 
of mice.  This  specificity  is  also  detected in  30%  of the 
(SWIL  x  SJL)F1 females,  all  of  them  with  anti-Sm/ 
UlsnRNP antibodies. None of the mice developed  antihis- 
tones, antierythrocyte antibodies, or rheumatoid factors (data 
not shown). A relationship between anti-Sm and anti-dsDNA 
antibodies has been described in MRL 1pr/lpr:  (a) anti-Sm 
and anti-DNA overlapping responses have been demonstrated 
in this strain of mice. The isolation of Sm/DNA-specific hy- 
bridomas may indicate a common origin of both autoanti- 
bodies (11); and (b) parallel  sets of autoantibodies have been 
reported in which Id-H130 is selected against DNA. How- 
ever other molecules with the same idiotype did not bind 
to DNA, but did bind to Sm antigens (12). Similar studies 
in the (SWR  x  SJL)F1 mice may be suitable for explaining 
this relationship. 
(SWR  x  SJL)F1  Mice: A New Model of Lupus-like Disease Anti-dsDNA autoantibodies correlate with the presence 
of proteinuria and immunocomplex nephropathy. All the 
animals with proteinuria had anti-dsDNA. Furthermore, mice 
with anti-Sm/UlsnRNP antibodies without anti-DNA an- 
tibodies did not show any pathologic disorder during the 
follow up. A relationship between anti-dsDNA autoantibodies 
and nephropathy by immunocomplexes has already been de- 
scribed in SLE patients as well as in SLE autoimmune strains 
of mice (13), 
SWR mice are free of autoimmune disease and autoanti- 
bodies,  although when the SWK strain of mice was crossed 
with NZB mice, the F1 progeny developed  a severe lupus 
with glomerulonephritis. However, when the NZB mice were 
crossed with other normal mice strains such as C57BL/6 and 
AKR no autoimmune diseases were developed  in their Ft 
progeny (14). These observations indicate that genes inherited 
from SWR strongly influence the expression of autoimmune 
disease in NZB crosses. Some immunologic alterations (IgA 
levels and lymphocyte subpopulation percentages  in spleen) 
in SWR mice are  similar to those observed  in (SWR,  x 
SJL)F1  mice,  suggesting  that  SWK  genes  dominantly 
influence the immunologic constitution of the hybrid mice. 
Furthermore SJL mice spontaneously developed neither au- 
toimmune disease nor autoantibodies (15), although SJL mice 
have been employed to develop experimental autoimmune en- 
cephalitis by immunization with myelin basic protein or pep- 
tides derived from this protein. In addition, some immuno- 
logic abnormalities have been described such as a quantitative 
deficit of Lyl  + B cells and a relative resistance  to tolerance 
induction (16). 
Several lines of evidence  suggest that the production of 
a mixed haplotype class II molecule, I-E~  d x  I-E/3  z, plays a 
key  role  in  development  of autoimmunity in  (NZB  x 
NZW)Ft  mice  (17). The  absence  of  I-E  molecules  in 
(SWR  x  SJL)F1 mice  excludes  this  possibility  in  this 
model. However SJL and SWR strains of mice might genet- 
ically complement each other in order to develop the SLE- 
like disease described in this paper. 
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